Fingerprint
Dive into the research topics of 'Defining SOD1 ALS natural history to guide therapeutic clinical trial design'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Defining SOD1 ALS natural history to guide therapeutic clinical trial design
Taha Bali, Wade Self, Jingxia Liu, Teepu Siddique, Leo H. Wang, Thomas D. Bird, Elena Ratti, Nazem Atassi, Kevin B. Boylan, Jonathan D. Glass, Nicholas J. Maragakis, James B. Caress, Leo F. McCluskey, Stanley H. Appel, James P. Wymer, Summer Gibson, Lorne Zinman, Tahseen Mozaffar, Brian Callaghan, April L. McVey
- Division of Public Health Sciences
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Section of Neuromuscular Medicine
- Center of Regenerative Medicine
- DBBS - Molecular Cell Biology
- DBBS - Neurosciences
- DBBS - Biochemistry, Biophysics, and Structural Biology
- Hope Center for Neurological Disorders
- Department of Neurology
Research output: Contribution to journal › Article › peer-review
74
Scopus
citations